Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment.

导出 LinkOut

翻译打印收藏纠错

第一作者： Laura,Cesini

第一单位： Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.

作者： Laura,Cesini ^[1] ; Agostina,Siniscalchi ^[2] ; Sara,Grammatico ^[1] ; Alessandro,Andriani ^[3] ; Alessia,Fiorini ^[4] ; Luca,De Rosa ^[5] ; Tommaso,Za ^[6] ; Angela,Rago ^[7] ; Tommaso,Caravita ^[2] ; Maria Teresa,Petrucci ^[1]

作者单位： Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy. ^[1] Institute of Haematology, S. Eugenio Hospital, Rome, Italy. ^[2] Department of Haematology, Nuovo Regina Margherita Hospital, Rome, Italy. ^[3] Department of Haematology, Belcolle Hospital, Viterbo, Italy. ^[4] Department of Haematology, S. Camillo Hospital, Rome, Italy. ^[5] Institute of Haematology, Catholic University, Rome, Italy. ^[6] Department of Cellular Biotechnologies and Haematology, Polo Pontino, Sapienza University of Rome, Latina, Italy. ^[7]

关键词 biochemical relapse cyclophosphamide dexamethasone, lenalidomide relapsed/refractory multiple myeloma

DOI 10.1111/ejh.13086

PMID 29719938

发布时间 2024-02-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

European journal of haematology

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment.

European journal of haematology

相似文献

European journal of haematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment.

European journal of haematology

相似文献

European journal of haematology

相关期刊

检索历史清除